Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.

Related Articles

Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.

Psychiatry Clin Neurosci. 2014 Oct 30;

Authors: Ota T, Iida J, Nakanishi Y, Sawada S, Matsuura H, Yamamuro K, Ueda S, Uratani M, Kishimoto N, Negoro H, Kishimoto T

Abstract
AIM: Atomoxetine, approved in Japan for the treatment of pediatric attention-deficit/hyperactivity disorder in April 2009, is a nonstimulant that is thought to act presynaptically via the inhibition of norepinephrine reuptake. Near-infrared spectroscopy is a noninvasive optical tool that can be used to study oxygenation and hemodynamic changes in the cerebral cortex. The present study examined the effects of a clinical dose of atomoxetine on changes in prefrontal hemodynamic activity in children with attention-deficit/hyperactivity disorder, as measured by near-infrared spectroscopy using the Stroop color-word task.
METHODS: Ten children with attention-deficit/hyperactivity disorder participated in the present study. We used 24-channel near-infrared spectroscopy to measure the relative concentrations of oxyhemoglobin in the frontal lobes of participants in the drug-naïve condition and those who had received atomoxetine for 8 weeks. Measurements were conducted every 0.1 s during the Stroop color-word task. We used the ADHD RS-IV-J (Home Version) to evaluate ADHD symptoms.
RESULTS: We found a significant decrease in ADHD RS-IV-J scores, from 30.7 to 22.6 (P=0.003). During the Stroop color-word task, we found significantly higher levels of oxyhemoglobin changes in the prefrontal cortex of participants in the atomoxetine condition compared with those in the drug-naïve condition.
CONCLUSIONS: This increase in oxyhemoglobin changes might indicate an intensified prefrontal hemodynamic response induced by atomoxetine. Near-infrared spectroscopy is a sensitive tool for measuring the pharmacological effects of atomoxetine in children with attention-deficit/hyperactivity disorder.

PMID: 25359429 [PubMed – as supplied by publisher]

via http://ift.tt/1xNPPO7